Emerging Anticoagulant Therapies for Atrial Fibrillation: New Options, New Challenges

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|27|4688-4698

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.27, 2012-09, pp. : 4688-4698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological therapy for atrial fibrillation: current options and new agents

By Viswanathan Mohan N   Page Richard L  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 417-431

Informa Healthcare

Access to resources Recommend Favorite

New antiarrhythmic agents for atrial fibrillation and atrial flutter

By Pecini Redi   Elming Hanne   Pedersen Ole Dyg   Torp-Pedersen Christian  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 311-322

Informa Healthcare

Access to resources Recommend Favorite

Dronedarone: A New Hope for Stroke Prevention in Atrial Fibrillation?

By Shantsila Alena   Lip Gregory Y.H.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 355-356

Adis International

Access to resources Recommend Favorite

Vernakalant for the Conversion of Atrial Fibrillation: The New Kid On the Block?

By Conde Diego   Baranchuk Adrian  

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 4, 2014-07 ,pp. : 299-302

Blackwell Publishing

Access to resources Recommend Favorite

Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

By  

Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. : 6096-6105

Bentham Science Publishers

Access to resources Recommend Favorite